Literature DB >> 2025837

In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck.

R Grénman1, T E Carey, K D McClatchey, J G Wagner, K Pekkola-Heino, D R Schwartz, G T Wolf, L P Lacivita, L Ho, S R Baker.   

Abstract

Twenty-five squamous cell carcinoma (SCC) cell lines from 20 patients with head and neck cancer were assessed for radiosensitivity in vitro using a 96-well plate assay. Four non-SCC lines were also tested. Radiation sensitivity of individual cell lines was compared using the area under the survival curve (AUC) as a measure of the mean inactivation dose. Tumor lines were tested with either a cobalt-60 (60Co) gamma-irradiator having a dose rate of 100 cGy/minute or with a 4-meV photon beam having a dose rate of 200 cGy/minute. The mean AUC of the 25 SCC cell lines was 188 +/- 7 (SEM) cGy (range, 100 to 250 cGy) whereas the four non-SCC lines had a mean AUC of 225 +/- 9 cGy. The SCC cell lines with mean inactivation dose values greater than 188 cGy were classified as relatively radioresistant whereas those with values less than 188 cGy were considered relatively radiosensitive. In seven cases SCC cell lines were derived from patients who had already received radiation therapy. In four of these cases the tumor cell lines were radioresistant (AUC, 210 to 250) but in the other three cases the tumor lines were radiosensitive (AUC, 160 to 180). Thus, failure of a tumor to respond to radiation did not always select for radioresistant cells. The mean of the AUC for cell lines from previously irradiated patients (197 +/- 11 cGy) did not differ significantly from that of the cell lines from patients who received no prior radiation therapy (182 +/- 9 cGy). However, among radiation-resistant lines those from the four previously irradiated patients were significantly more resistant (mean AUC = 235 +/- 9) than seven other radioresistant lines from nonirradiated patients (mean AUC, 208 +/- 4) (P = 0.0194). In four cases more than one cell line was derived from different tumor specimens in the same patient. In each of these cases the lines from the same patients were similar to one another in their degree of radioresistance. Based on these observations the authors conclude that the degree of in vitro radiation resistance is an inherent property of some squamous cell tumors.

Entities:  

Mesh:

Year:  1991        PMID: 2025837     DOI: 10.1002/1097-0142(19910601)67:11<2741::aid-cncr2820671105>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  29 in total

1.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

2.  In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines.

Authors:  Mei Zhang; Barbara Rose; C Soon Lee; Angela M Hong
Journal:  Cancer Biol Ther       Date:  2015-06-05       Impact factor: 4.742

3.  Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas.

Authors:  Weiping Zhang; Neil Bhola; Shailaja Kalyankrishna; William Gooding; Jennifer Hunt; Raja Seethala; Jennifer R Grandis; Jill M Siegfried
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

4.  Broccoli extract improves chemotherapeutic drug efficacy against head-neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ramy Ashry; Ghada Abu Elghanam; Hieu M Pham; Xinyun Su; Camille Stegen; Simon D Tran
Journal:  Med Oncol       Date:  2018-08-04       Impact factor: 3.064

5.  Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma.

Authors:  K Pekkola-Heino; M Jaakkola; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.

Authors:  Changyou Li; Rongxiu Li; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

7.  Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.

Authors:  Lihua Hu; Jingpeng Liu; Zhi Li; Chunling Wang; Ali Nawshad
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-06-08

8.  Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines.

Authors:  J Chad Brenner; Martin P Graham; Bhavna Kumar; Lindsay M Saunders; Robbi Kupfer; Robert H Lyons; Carol R Bradford; Thomas E Carey
Journal:  Head Neck       Date:  2010-04       Impact factor: 3.147

Review 9.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.

Authors:  Rongxiu Li; Amanda L Boehm; Michelle B Miranda; Sanjeev Shangary; Jennifer R Grandis; Daniel E Johnson
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.